Humira (adalimumab) - Articles and news items

Samsung Bioepis seeks EU approval for its biosimilar adalimumab candidate, SB5

Industry news / 18 July 2016 / Victoria White, Digital Content Producer

At an estimated $4billion a year, the reference product, Humira, is among the European Union’s largest single drug expenditures…

AbbVie announces study data for Humira in fingernail psoriasis

Industry news / 7 July 2016 / Victoria White, Digital Content Producer

Nearly half of adult patients treated with Humira achieved at least a 75% improvement in their fingernail psoriasis compared to patients receiving placebo…

Novartis plans head-to-head studies of Cosentyx versus Humira

Industry news / 8 June 2016 / Victoria White, Digital Content Producer

Long-term analyses suggest Cosentyx may lead to higher responses than Humira in improving signs and symptoms of ankylosing spondylitis and psoriatic arthritis…

Abbott logo
Abbott logo

Abbott receives positive opinion for HUMIRA® in non-radiographic axial spondyloarthritis from EMA’s CHMP

Industry news, News / 25 June 2012 / Abbott

Abbott announced that the CHMP has issued a positive opinion for HUMIRA®…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...